比索洛尔与曲美他嗪联用对高血压心肌肥厚患者心肌重构的抑制作用

摘要

Objective To investigate the myocardial remodeling inhibition effect of bisoprolol combined with trimetazidine in the treatment of hypertensive myocardial hypertrophy.Methods 86 cases with hypertension and cardiac hypertrophy in Lingwu People’s Hospital of Ningxia from June 2015 to June 2016 were selected and randomly divided into two groups,43 cases in the control group received routine clinical treatment,43 cases in the experiment group received more with bisoprolol combined with trimetazidine treatment.Blood pressure,ultrasonic cardiogram,levels of serum TNF-α, MMP3 and CRP were compared before and after the treatment.Results Compared with before treatment,levels of blood pressure,IVST,LVPWT,LVMI, MMP3,TNF-αand serum CRP significantly decreased after treatment,and compared with the control group,levels of blood pressure,IVST,LVPWT, LVMI,MMP3,TNF-αand serum CRP in the experiment group were lower,the differences were statistically significant (P<0.05),and the effective rate in the experiment group was higher than the control group ( P<0.05 ) .Conclusion Bisoprolol combined with trimetazidine can effectively inhibit the remodeling of hypertension in patients with myocardial hypertrophy,has good clinical efficacy.%目的：探讨比索洛尔与曲美他嗪联用对高血压心肌肥厚患者心肌重构影响的研究。方法选取2015年6月～2016年6月于宁夏灵武市人民医院以高血压合并心肌肥厚为诊断而收入院的患者86例，随机分为2组，对照组43例，予临床常规治疗；实验组43例，予比索洛尔联合曲美他嗪治疗。观察2组患者治疗前后血压、心脏彩超、肿瘤坏死因子－α（ tumor necrosis factor－α，TNF－α）、基质金属蛋白酶－3（MMP3）、C反应蛋白（C－reactive protein，CRP）水平变化。结果与治疗前比较，2组患者治疗后的血压、室间隔厚度（IVST）、舒张末左心室后壁厚度（LVPWT）、左心室质量指数（LVMI）以及血清TNF－α、MMP3、CRP水平均明显降低；治疗后与对照组比较，实验组血压、IVST 、LVPWT、LVMI以及血清TNF－α、MMP3、CRP水平均明显低于对照组，以上结果差异均有统计学意义（ P＜0．05），实验组的总有效率为81．40％，高于对照组的总有效率58．14％（P＜0．05）。结论比索洛尔与曲美他嗪联合应用能有效抑制高血压心肌肥厚患者心肌重构，具有较好的临床疗效。